Who Paid My Doc
R3 Acetabular
Device Recon Hips
PDI 03596010598240
General payments
$1,376,936
Research payments
$126,554
Through program year 2025, $1,376,936 in general payments and $126,554 in research payments were reported against R3 Acetabular (Recon Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $173,508 | 91 |
| 2024 | General | $410,619 | 383 |
| 2024 | Research | $30,863 | 17 |
| 2023 | General | $651,799 | 254 |
| 2023 | Research | $41,433 | 20 |
| 2022 | General | $141,010 | 254 |
| 2022 | Research | $54,259 | 26 |
Breakdown
The top 5 of 59 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
982 general · 63 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.